# OnCo record paper-cd19-all-leukemia-j-clin-oncol-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cd19-all-leukemia-j-clin-oncol-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cd19-all-leukemia-j-clin-oncol-2014" ;
  schema:name "Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia"@en ;
  schema:description "Phase 2 or 3 results paper on CD19 in Acute lymphoblastic leukaemia, in Journal of Clinical Oncology (2014), one of the most cited Europe PMC records with CD19 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-cd19-all-leukemia-j-clin-oncol-2014/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.2014.56.3247>, <https://pubmed.ncbi.nlm.nih.gov/25385737/>, <https://europepmc.org/article/MED/25385737> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.2014.56.3247> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Topp MS, Gökbuget N, Zugmaier G, et al." ;
  onco:journals <https://onco.cc/journals/jco/> .